Bank Of New York Mellon Corp Titan Pharmaceuticals Inc Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.87 - $2.57 $28,792 - $39,570	-15,397 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.24 - $2.9 $6,287 - $8,140	-2,807 Reduced 15.42%	15,397 $40,000
Q1 2021 May 13, 2021	BUY	$2.66 - $4.23 $48,422 - $77,002	18,204 New	18,204 $54,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $58.5M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.